HOME >> BIOLOGY >> NEWS
Study investigates breast cancer resistance to tamoxifen and possible way to reverse it

A new study has found a possible mechanism for tamoxifen resistance in breast cancer and provides evidence that another cancer drug--gefitinib (Iressa)--may be able to restore tamoxifen's anticancer activity. The study appears in the June 16 issue of the Journal of the National Cancer Institute.

Although adjuvant tamoxifen can reduce the risk of death for women with invasive breast cancer by about 15% over 10 to 15 years, many women do not receive any benefit from the drug. Even among patients most likely to benefit from tamoxifen--those with tumors that express the drug's target, the estrogen receptor (ER)--only 40% to 50% actually benefit. Studies have shown that patients with ER-positive tumors that express high levels of HER2/neu and the ER coactivator AIB1 often develop tamoxifen resistance, but the mechanism of the resistance has not been identified.

To find this mechanism, Rachel Schiff, Ph.D. and C. Kent Osborne, M.D., of the Baylor College of Medicine in Houston, and colleagues studied molecular interactions in breast cancer cells that expressed high levels of both HER2 and AIB1. They found that, in these cells, tamoxifen acted like an estrogen agonist and stimulated tumor growth. However, when the breast cancer cells were treated with the receptor tyrosine kinase inhibitor gefitinib, tamoxifen once again acted as an estrogen antagonist and tumor growth was blocked.

"Our data imply that monotherapy with growth factor pathway inhibitors like gefitinib may have little or only modest benefits on ER-positive, HER2-overexpressing breast cancer, but the results do provide a strong rationale for combining tamoxifen with gefitinib or other EGFR/HER2 pathway inhibitors to overcome resistance in such tumors. Clinical trials of this new strategy are under way," the authors write.

In an editorial, Daniel F. Hayes, M.D., of the University of Michigan Health System in Ann Arbor, reviews tamoxifen's potential for both harm and good
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
15-Jun-2004


Page: 1 2

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... March 28, 2019 , ... In the development of biosimilars, ... a path for this task. Despite this uncertainty, several manufacturers have been successful and ... the first part of this webinar, learn how analytical similarity is achieved in biosimilars ...
(Date:3/27/2019)... ... 2019 , ... Evan Holden , a shareholder in the Atlanta ... at the National Academy of Sciences (NAS) Roundtable on Biomedical Engineering Materials Applications (BEMA), ... firm’s award-winning Pharmaceutical, Medical Device & Health Care Litigation Practice , addressed, “Medical ...
(Date:3/25/2019)... ... 25, 2019 , ... Researchers have found multiple applications for ... came into use by the scientific community. Keck Graduate Institute (KGI) Assistant Professor ... combine the power of CRISPR’s nucleic acid targeting with the ultra sensitivity of ...
Breaking Biology News(10 mins):
(Date:4/4/2019)... , ... April 03, 2019 , ... ... through intimate off-the-record collaboration and dialogue, today announces its Boston CEO conference to ... insights into the industry’s challenges and opportunities with high-level panels and discussions from ...
(Date:3/27/2019)... ... 27, 2019 , ... In honor of National Nutrition Month, Lajollacooks4u has collaborated ... meals and good nutrition. This month, Chef Jodi Abel appeared on two segments ... , The first segment addressed the nutritional value of USDA’s MyPlate, a nutrition guide ...
(Date:3/23/2019)... KING OF PRUSSIA, Pa. (PRWEB) , ... March ... ... announce the introduction of its LenS3 Multi-Angle Light Scattering (MALS) detector , ... of gyration (Rg) of synthetic polymers, polysaccharides, proteins, and biopolymers. A novel optical ...
(Date:3/19/2019)... ... ... old when he injured both of his cruciate ligaments. On top of that, Bogey ... with his mobility. According to his owners, he could barely walk and required assistance ... owners, devastated at the sight of Bogey in so much pain and the possibility that ...
Breaking Biology Technology:
Cached News: